 |
 |
 |
 |
 |
|
|
Contact | Print version | PDF version | Send article | RSS feed
S*Bio and A*Star to develop new compounds to treat cancer08 Feb 2007 -
S*BIO Pte Ltd, a privately held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer, announced that it has signed a two-year Master Research Collaboration Agreement with the Agency for Science, Technology and Research's (A*STAR) Institute of Molecular and Cell Biology (IMCB) for thediscovery and development of multiple compounds for the treatment of cancer.
Promising compounds may be further developed by A*STAR's newly formed Experimental Therapeutics Centre (ETC) and S*BIO to advance these compounds towards clinical development.
Additional information
Agency for Science, Technology and Research (A*STAR) Singapore, Singapore
News
|
S*BIO Pte Ltd Singapore, Singapore
News
|
News regarding Cooperation
|
|
|
|
|